Filariasis News and Research

RSS

Filariasis (Philariasis) is a parasitic and infectious tropical disease, that is caused by thread-like filarial nematode worms in the superfamily Filarioidea, also known as "filariae". There are 9 known filarial nematodes which use humans as the definitive host.

Drug Discovery 2023: A Conversation with Professor Janet Hemingway

We spoke to Professor Janet Hemingway, founding Director of iiCON and Professor of Tropical Medicine at Liverpool School of Tropical Medicine.

9 Oct 2023

University Hospital Bonn coordinates eWHORM project to combat worm infections in sub-Saharan Africa

African and European partners join forces to enable the World Health Organisation's (WHO) "Road Map for Neglected Tropical Diseases" (NTDs) and reduce the burden of disease associated with worm infections.

11 Apr 2023

Women and girls are disproportionately affected by climate change

The adverse effects of climate change have impacted numerous areas of human health and well-being. In most parts of the world, women are least able to mitigate such changes, so they are an appropriate focus in a recent research paper.

19 Feb 2023

Modulation of insect immunity to control vector-borne diseases

Discussed the current research on the role of molecular mechanisms in mediating immune priming in insects and regulating vector-borne disease transmission.

19 Dec 2022

Q&A: COVID-19 pandemic has widened gender inequities in health

Health inequalities facing women and girls, already stark before the onset of COVID-19, have widened glaringly during the pandemic. Lockdowns restricted access to sexual and reproductive health services, increased violence against women, and interrupted girls’ education.

9 May 2022

Sri Lanka’s healthcare system heavily affected by the current economic crisis

Sri Lanka's acute economic crisis has begun to tell on its health care system with critical medicines running out for want of hard currency to import supplies, experts say.

22 Apr 2022

New drug targeting LF and onchocerciasis begins its first in human trial in Liverpool

A new drug developed by an LSTM led partnership, which targets the neglected tropical diseases lymphatic filariasis and onchocerciasis has begun its first in human trial.

6 Jan 2022

WHO and Sanofi sign new agreement to sustain specific efforts to eliminate NTDs

The World Health Organization (WHO) and Sanofi – one of the world's leading pharmaceutical companies – have signed a new agreement for donations of medicines to sustain specific efforts to eliminate neglected tropical diseases (NTDs).

16 Dec 2021

Researchers examine whether community administration of ivermectin influences malaria transmission

Researchers from the LSTM based Cochrane Infectious Disease Group explored whether community administration of ivermectin influences malaria transmission.

29 Jun 2021

New genetic editing tools could stop the spread of mosquito diseases

Since the onset of the CRISPR genetic editing revolution, scientists have been working to leverage the technology in the development of gene drives that target pathogen-spreading mosquitoes such as Anopheles and Aedes species, which spread malaria, dengue and other life-threatening diseases.

29 May 2021

Infrared thermal imaging camera can help monitor the progression of lymphatic filariasis

A paper published in the Journal of Clinical Medicine presents the results from a study which examined the use of an infrared thermal imaging camera as a novel non-invasive point-of-care tool for lymphatic filariasis lower-limb lymphoedema.

26 May 2021

WHO releases new strategy on water, sanitation and hygiene to end neglected tropical diseases

Today, on World Water Day, the World Health Organization (WHO) released its strategy on water, sanitation and hygiene as part of joint efforts by the water, sanitation and hygiene (WASH) and the neglected tropical diseases (NTD) sectors towards ending these diseases over the next decade.

23 Mar 2021

Filariasis News and Research

Further Reading

Drug Discovery 2023: A Conversation with Professor Janet Hemingway

University Hospital Bonn coordinates eWHORM project to combat worm infections in sub-Saharan Africa

Women and girls are disproportionately affected by climate change

Modulation of insect immunity to control vector-borne diseases

Q&A: COVID-19 pandemic has widened gender inequities in health

Sri Lanka’s healthcare system heavily affected by the current economic crisis

New drug targeting LF and onchocerciasis begins its first in human trial in Liverpool

WHO and Sanofi sign new agreement to sustain specific efforts to eliminate NTDs

Researchers examine whether community administration of ivermectin influences malaria transmission

New genetic editing tools could stop the spread of mosquito diseases

Infrared thermal imaging camera can help monitor the progression of lymphatic filariasis

WHO releases new strategy on water, sanitation and hygiene to end neglected tropical diseases

New evidence supports ivermectin use in children weighing less than fifteen kilograms

Countries with older populations have higher SARS-CoV-2 infections and deaths, says study

Ivermectin may not be the ‘silver bullet’ antiviral against COVID-19

Could Ivermectin be an effective antiviral against SARS-CoV-2?

Scientists decipher the structure of protein found in parasites that cause neglected tropical diseases

Researchers receive $2.95 million grant to create improved diagnostics for worm infections

Researchers identify traditional Ghanaian medicines to eradicate neglected tropical diseases

World Health Organization, Sanofi sign new agreement to eliminate neglected tropical diseases

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News